Skip to main content

Find Clinical Trials

Home
Conditions
Prurigo Nodularis

Clinical trial condition

Prurigo Nodularis

Explore clinical trials studying Prurigo Nodularis. Study availability and eligibility vary by location and protocol.

35 public trials 6 recruiting studies

Refine in advanced search Browse all conditions

Prurigo Nodularis trial results

Completed

A Randomized Placebo-Controlled Study of the Neurokinin-1 (NK1) Receptor Antagonist Serlopitant Prurigo Nodularis (PN)

NCT02196324

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +11 more
Locations: Study Site 08 Bonn, Germany

Study Site 06 Dresden, Germany

Study Site 12 Düsseldorf, Germany

Study Site 02 Frankfurt, Germany

View all 15 locations

View Trial Details

Completed

Pain Outcomes Following Intralesional Corticosteroid Injections

NCT03630198

Conditions: Acne, Acne Vulgaris, Acneiform Eruptions, +41 more
Locations: Vanderbilt University Medical Center Nashville, Tennessee, United States

View Trial Details

Completed

Safety and Efficacy of Nemolizumab in PN

NCT03181503

Conditions: Prurigo Nodularis
Locations: LKH-Univ. Klinikum Graz Graz, Austria

Centre-Hospitalier Universitaire (CHU) - Hopital Morvan - Br Brest, France

CHU de Nice - Hôpital Archet 2 Nice, France

Hopital Saint-Louis - Dermatology Paris, France

View all 16 locations

View Trial Details

Completed

Safety and Efficacy of CC-10004 for Prurigo Nodularis

NCT00869089

Conditions: Prurigo Nodularis
Locations: University Hospitals Cleveland Medical Center Cleveland, Ohio, United States

View Trial Details

Completed

Evaluation of the Antipruritic Effect of Elidel (Pimecrolimus) in Non-atopic Pruritic Disease

NCT00507832

Conditions: Prurigo Nodularis
Locations: Department of Dermtology, University of Münster Münster, Germany

View Trial Details